Skip to main content

Full FDA approval of Pfizer’s and Moderna’s COVID-19 shots would reinvigorate the U.S. vaccination push — but it could still be months away

The "full" approval of Pfizer and Moderna's COVID-19 vaccines sometime this year could boost sagging vaccination rates in the U.S., though the Food and Drug Administration's decision may not happen until the end of the year.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.